Home > Biotech and Pharmaceutical Companies > California Biotech and Pharmaceutical Companies

Sunesis Pharmaceutical Inc

Sunesis Pharmaceutical Inc (395 Oyster Point Blvd, South San Francisco, CA 94080) from the Biotech and Pharmaceutical Companies Directory

Sunesis Pharmaceutical Inc

Address:

395 Oyster Point Blvd
South San Francisco, CA 94080

Phone:

(650) 266-3500

Website:

See Also:

California Biotech and Pharmaceutical Companies

Map

About

This is a business listing for Sunesis Pharmaceutical Inc, located in South San Francisco, CA. You can find them at 395 Oyster Point Blvd, South San Francisco, CA, 94080, contact them at (650) 266-3500, or visit their website. This listing is provided by colorbasepair.com as part of our Biotech and Pharmaceutical Companies directory, under California Biotech and Pharmaceutical Companies.

Frequently Asked Questions About Sunesis Pharmaceutical Inc

What services does Sunesis Pharmaceutical Inc offer?

This listing provides contact information for Sunesis Pharmaceutical Inc. For details about the specific services they offer, please visit their website or contact them directly.

Where is Sunesis Pharmaceutical Inc located?

Sunesis Pharmaceutical Inc is located at: 395 Oyster Point Blvd, South San Francisco, CA 94080.

What is the phone number for Sunesis Pharmaceutical Inc?

The phone number for Sunesis Pharmaceutical Inc is: (650) 266-3500.

What is the website for Sunesis Pharmaceutical Inc?

Sunesis Pharmaceutical Inc's website is: https://www.satsumarx.com.

How can I contact Sunesis Pharmaceutical Inc?

You can contact Sunesis Pharmaceutical Inc by phone at (650) 266-3500. You can also visit their website at: https://www.satsumarx.com.

Other Listings

You can find more similar services in California Biotech and Pharmaceutical Companies from our Biotech and Pharmaceutical Companies Directory.

Here are some other listings in the South San Francisco, CA Biotech and Pharmaceutical Companies Directory: Merck, Takeda Pharmaceuticals America Inc, Oculeve, Sutro Biopharma Inc, Kezar Life Sciences.